World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: EUCTR
Last refreshed on: 18 April 2012
Main ID:  EUCTR2005-003048-78-IT
Date of registration: 02/03/2006
Prospective Registration: No
Primary sponsor: PFIZER
Public title: A 9-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, STUDY OF PREGABALIN BID IN SUBJECTS WITH POSTTRAUMATIC PERIPHERAL NEUROPATHIC PAIN
Scientific title: A 9-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, STUDY OF PREGABALIN BID IN SUBJECTS WITH POSTTRAUMATIC PERIPHERAL NEUROPATHIC PAIN
Date of first enrolment: 25/11/2005
Target sample size: 260
Recruitment status: Not Recruiting
URL:  https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-003048-78
Study type:  Interventional clinical trial of medicinal product
Study design:  Controlled: yes Randomised: yes Open: no Single blind: no Double blind: yes Parallel group: yes Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: yes Other: no  
Phase: 
Countries of recruitment
Denmark Finland Italy Portugal Sweden United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion criteria:


Age minimum:
Age maximum:
Gender:
Female: yes
Male: yes
Health Condition(s) or Problem(s) studied
Treatment of post-traumatic peripheral neuropathic pain in adults
MedDRA version: 6.1 Level: PT Classification code 10034586
Intervention(s)

Trade Name: Lyrica
Pharmaceutical Form: Capsule, hard
Current Sponsor code: CI-1008
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number: 75-

Trade Name: Lyrica
Pharmaceutical Form: Capsule, hard
Current Sponsor code: CI-1008
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number: 150-

Trade Name: Lyrica
Pharmaceutical Form: Capsule, hard
Current Sponsor code: CI-1008
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number: 300-

Primary Outcome(s)
Primary end point(s):
Secondary Objective:
Main Objective:
Secondary Outcome(s)
Secondary ID(s)
A0081064
2005-003048-78-SE
Source(s) of Monetary Support
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history